Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Bortezomib for Injection

Approval Number

国药准字H20244587

Company仁合熙德隆药业有限公司

Registration Date

July 30, 2024

Drug Information

Generic Name

注射用硼替佐米

Dosage Form

注射剂

Strength

3.5mg

Drug Type

化学药品

Registration Date

July 30, 2024

Company Information

Applicant Company

Company Name仁合熙德隆药业有限公司

Company Address

河南省郑州市中牟县官渡生物医药产业园区结义路20号

Manufacturing Company

Company Name仁合熙德隆药业有限公司

Company Address

河南省郑州市中牟县官渡生物医药产业园区结义路20号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy